Genetic Risk Factors for Major Depressive Disorder
Author Information
Author(s): Garriock Holly A, Delgado Pedro, Kling Mitchel A, Carpenter Linda L, Burke Michael, Burke William J, Schwartz Thomas, Marangell Lauren B, Husain Mustafa, Erickson Robert P, Moreno Francisco A
Primary Institution: University of Arizona
Hypothesis
The depressive group as a whole would be genetically distinct from the healthy controls.
Conclusion
The study supports an association between several monoamine-related genes and Major Depressive Disorder, suggesting that genetic susceptibility and treatment response may be independent.
Supporting Evidence
- A significant difference in genotype frequency for the SLC6A4 intron 2 VNTR was found between depressed subjects and controls.
- Responders and non-responders showed a significant difference in DRD4 exon III VNTR genotype frequencies.
- Depressed subjects had more risk genotypes than non-depressed subjects.
Takeaway
This study looked at the genes of people with depression and found that those who don't respond to treatment have different genetic markers than those who do.
Methodology
A candidate gene approach was used to assess genetic differences among depressed subjects and controls.
Potential Biases
Potential type I error due to multiple comparisons and the younger age of controls compared to depressed groups.
Limitations
The sample size was relatively small, which may affect the reliability of the findings.
Participant Demographics
Subjects were aged 18 to 85, predominantly Caucasian, with 66.7% female representation.
Statistical Information
P-Value
0.004 for SLC6A4 intron 2 VNTR, 0.009 for DRD4 exon 3 VNTR
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website